All Posts By

Smartkarma Newswire

China Merchants Port (144) Earnings Surpass Estimates with HK$7.92 Billion FY Net Income

By | Earnings Alerts
  • China Mer Port reported a net income of HK$7.92 billion for the fiscal year.
  • This net income figure surpassed the estimated amount of HK$7.59 billion.
  • Revenue came in at HK$11.84 billion, slightly below the estimated revenue of HK$12 billion.
  • Analyst recommendations show 5 buys, 4 holds, and 0 sells for China Mer Port.

China Merchants Port on Smartkarma

Analysts on Smartkarma, such as Osbert Tang, CFA, are closely following China Merchants Port (144 HK) and its potential role in CK Hutchison’s port sale. In a report titled “China Merchants Port (144 HK): Will It Have a Role in CKH’s Port Sale?” by Osbert Tang, it is suggested that China Merchants Port may play a part in CK Hutchison’s port portfolio disposal, especially if there is government intervention. Tang highlights that mainland ownership of ports is desirable, and considers CMPH to have attractive valuations. Despite CMPH’s smaller size relative to the port portfolio, its parent company China Merchants Group and sister company China Merchants Bank H (3968 HK) could facilitate such a transaction. The Chinese government finds having the port portfolio in the hands of a mainland company desirable, making CMPH a potentially significant player in this scenario.

The report by Osbert Tang also emphasizes the appealing valuation metrics of China Merchants Port (144 HK), citing a price-to-earnings ratio of 7.6x and a 6% yield. Even if China Merchants Port has no direct role in the port sale, these financial metrics make it an attractive investment opportunity. Tang’s analysis underscores the importance of considering the broader context of government preferences and the potential involvement of related companies like China Merchants Group and China Merchants Bank H in evaluating the investment potential of China Merchants Port. Investors seeking opportunities in the port sector may find the insights provided by analysts like Tang on Smartkarma valuable in making informed decisions regarding China Merchants Port.


A look at China Merchants Port Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Merchants Port, a subsidiary of China Merchants Holdings International Company Limited, shows promising long-term potential according to the Smartkarma Smart Scores. With a strong value score of 4, indicating an attractive valuation, investors can view China Merchants Port as a sound investment opportunity. Additionally, the company scores well in momentum, with a score of 4, suggesting positive price trends and investor sentiment. This bodes well for the company’s future performance as it indicates strong market interest and potential for growth.

While China Merchants Port scores moderately on factors such as dividend, growth, and resilience, each with a score of 3, the overall outlook remains optimistic. The company’s diverse operations in container and cargo terminals, port transportation, and various other businesses provide a solid foundation for potential growth and stability. Investors looking for a value-oriented investment with growth potential may find China Merchants Port an appealing long-term prospect based on the Smartkarma Smart Scores.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

China Overseas Land & Investment (688) Earnings: FY Net Income Falls Short of Estimates, Revenue and Gross Margin Also Below Forecasts

By | Earnings Alerts
  • China Overseas Land reported a net income of 15.64 billion yuan, which was below the estimated 22.55 billion yuan.
  • Revenue for the fiscal year was 185.15 billion yuan, falling short of the expected 200.96 billion yuan.
  • The company’s net gearing ratio stands at 29.2%.
  • Total debt amounts to 241.56 billion yuan.
  • China Overseas Land has cash and bank balances totaling 124.17 billion yuan, exceeding the projected 113.23 billion yuan.
  • The gross margin is at 17.7%, which is lower than the estimated 19.2%.
  • Final dividend per share announced is 30 HK cents.
  • The company’s stock has received 28 buy recommendations, 4 hold positions, and no sell recommendations from analysts.

A look at China Overseas Land & Investment Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth3
Resilience2
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Overseas Land & Investment Limited, a global provider of real estate services, is positioned with a promising long-term outlook according to Smartkarma’s Smart Scores. With a strong Value score of 4, the company is perceived to be attractively priced based on its fundamentals. Additionally, receiving a solid Momentum score of 4 suggests positive market sentiment and potential for future growth.

While the company exhibits decent Growth and Dividend scores of 3 each, indicating steady development and income distribution to investors, its Resilience score of 2 flags some level of vulnerability to external economic factors. Overall, with a blend of favorable scores in key areas, China Overseas Land & Investment appears well-equipped to navigate the real estate market terrain and potentially deliver value to its stakeholders in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Maxscend Microelectronics L (300782) Earnings Fall Short of Expectations: Net Income at 401.8 Million Yuan

By | Earnings Alerts
  • Maxscend’s net income for the fiscal year was 401.8 million yuan.
  • The net income fell short of the estimated 509.4 million yuan.
  • Total revenue reported was 4.49 billion yuan.
  • This revenue figure was below the projected 4.54 billion yuan.
  • Analyst recommendations include 20 buy ratings.
  • There are 5 hold ratings for Maxscend.
  • 3 analysts have issued sell ratings.

A look at Maxscend Microelectronics L Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE2.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Maxscend Microelectronics Company Limited’s long-term outlook looks promising based on the Smartkarma Smart Scores analysis. With above-average scores in Growth, Resilience, and Momentum, the company signals a positive trajectory for the future. The company’s strong performance in Growth and Resilience indicates its potential for expansion and ability to withstand market challenges. Additionally, the Momentum score suggests increasing investor interest and market performance.

Maxscend Microelectronics, a manufacturer of electrical components, specializing in smart phone RF switches and related products, holds moderate scores in Value and Dividend. While there may be room for improvement in these areas, the overall outlook remains favorable, especially considering the company’s focus on products for high-demand sectors such as automotive, smart phone, and infrastructure. This alignment with key industries positions Maxscend Microelectronics well for sustained growth and market relevance in the long term.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

PetroChina (857) Earnings: FY IFRS Net Falls Short of Estimates Amid Revenue Decline

By | Earnings Alerts
  • PetroChina‘s IFRS net income for the fiscal year is 164.68 billion yuan, slightly below the estimate of 168.07 billion yuan.
  • The company’s total revenue stands at 2.94 trillion yuan, which also misses the projected 3.04 trillion yuan.
  • Following the financial report, PetroChina‘s shares fell by 2.1% to HK$6.160 with a trading volume of 137.6 million shares.
  • The company’s stock currently has 23 buy recommendations, 1 hold, and 1 sell recommendation from analysts.

A look at PetroChina Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth4
Resilience3
Momentum3
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, PetroChina seems to have a positive long-term outlook. With top scores in Value and Dividend, indicating strong financial health and consistent dividend payments, the company appears to be a reliable choice for investors looking for stability and returns. Additionally, its above-average scores in Growth suggest potential for future expansion and profitability.

Although PetroChina receives slightly lower scores in Resilience and Momentum, these factors do not overshadow its overall positive outlook. With a diversified business model that includes exploration, production, refining, and distribution, PetroChina is well-positioned in the energy sector despite facing some challenges. Investors may find comfort in the company’s strong foundation and consistent performance over time.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Jiangsu Hengrui Medicine (600276) Earnings: FY Net Income Exceeds Estimates with 47.3% Increase

By | Earnings Alerts
  • Jiangsu Hengrui’s full year net income reached 6.34 billion yuan, surpassing estimates of 6.01 billion yuan.
  • The company’s revenue for the year was 27.98 billion yuan, exceeding the expected 27.03 billion yuan.
  • A final dividend per share was declared at 20 RMB cents, slightly below the estimate of 22 RMB cents.
  • Earnings per share for the year stood at 1.00 yuan.
  • Net income witnessed a significant increase of 47.3% compared to the previous year.
  • Market sentiment includes 30 buy ratings, 5 hold ratings, and 1 sell rating for the company’s stock.

Jiangsu Hengrui Medicine on Smartkarma




Analyst Coverage of <a href="https://smartkarma.com/entities/jiangsu-hengrui-medicine-co-ltd">Jiangsu Hengrui Medicine</a> on Smartkarma

Analysts on Smartkarma are closely monitoring Jiangsu Hengrui Medicine, with a focus on recent developments in the pharmaceutical company. Tina Banerjee‘s analysis highlights Hengrui’s exclusive deal with Merck for HRS-5346, a potential game-changer in cardiovascular drugs, with substantial upfront and milestone payments. The company’s strong revenue growth and profit increase are also noted, setting the stage for its upcoming full-year results announcement.

Moreover, perspectives from Ke Yan, CFA, FRM, and Sumeet Singh compare Hengrui’s H-share listing to peers like Hansoh Pharma, indicating a premium valuation. In contrast, Xinyao (Criss) Wang adopts a more cautious stance, questioning Hengrui’s high valuation in the face of business transformation challenges. Brian Freitas discusses the potential index inclusion post H-share listing, with Jiangsu Hengrui Medicine aiming for a significant raise through its HKEX listing, signaling growth opportunities amidst market dynamics.




A look at Jiangsu Hengrui Medicine Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth4
Resilience5
Momentum2
OVERALL SMART SCORE3.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, Jiangsu Hengrui Medicine shows promising long-term prospects. With high scores in Growth and Resilience, the company is positioned for future expansion and has demonstrated stability in challenging market conditions. Coupled with moderate scores in Value and Dividend, investors may find Jiangsu Hengrui Medicine to be a solid choice for sustained growth and potential returns.

Jiangsu Hengrui Medicine Co., Ltd. is a company that specializes in the development, manufacturing, and marketing of a diverse range of medicines and medicine packaging materials. Its product portfolio includes anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and related items. With a strong focus on innovation and product quality, the company aims to meet the healthcare needs of its customers effectively.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Tsingtao Brewery Co Ltd A (600600) Earnings: FY Revenue Hits 32.14B Yuan, Aligns with Estimates

By | Earnings Alerts
  • Tsingtao Brewery’s full-year revenue for the fiscal year met market expectations.
  • Reported revenue was 32.14 billion yuan, closely aligning with the estimated 32.17 billion yuan.
  • The company achieved a net income of 4.34 billion yuan.
  • Earnings per share (EPS) stood at 3.187 yuan.
  • Analyst recommendations include 24 buys, 5 holds, and 1 sell.

A look at Tsingtao Brewery Co Ltd A Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth4
Resilience5
Momentum2
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Tsingtao Brewery Co Ltd A has a solid long-term outlook. The company scores well in Dividend and Growth, indicating a positive outlook for generating returns for investors. Tsingtao also scores high in Resilience, suggesting strong stability and ability to weather market fluctuations. However, its Momentum score is relatively lower, which might indicate some challenges in terms of short-term performance. Overall, Tsingtao Brewery appears to be a promising investment opportunity with a focus on consistent dividends and sustainable growth.

As a producer and distributor of beer products, Tsingtao Brewery Company Limited holds a reputable position in the market. Known for its Tsingtao Beer brand, the company has a strong presence not only in China but also globally. With a focus on value, dividends, growth, and resilience, Tsingtao Brewery demonstrates a commitment to delivering quality products and maintaining financial stability. Investors looking for a company with a solid track record and a steady growth trajectory may find Tsingtao Brewery Co Ltd A a compelling investment option.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 30 Mar 2025

By | Private Markets, Smartkarma Newswire

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. KKR acquires FUJI SOFT in Japan
  2. Domino’s Pizza divestment in Indonesia finalized
  3. Everstone Capital exits fast food brand
  4. Private equity fundraising in Southeast Asia remains lackluster
  5. Optimism in the Philippines with robust IPO pipeline
  6. Potential $5 billion sale of Global Healthcare Exchange in the works
  7. Asia PE-VC Summit in Singapore announces first batch of speakers
  8. KKR eyes Topcon acquisition in Japan
  9. EQT vies for stake in Indian firm SLK Software
  10. NCS acquires majority stake in Yondu Inc. in joint venture with Globe and Singtel

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma